Abstract:BackgroundInflammatory and degenerative activity inside the joint can be studied in vivo by analysis of synovial fluid biomarkers. In addition to pro-inflammatory mediators, several anabolic and anti-inflammatory substances are produced during the disease process. They counteract the catabolic effects of the pro-inflammatory cytokines and thus diminish the cartilage damage. The response of synovial fluid biomarkers after intra-articular hyaluronan injection, alone or in combination with other substances, has been examined only in a few equine studies. The effects of hyaluronan on some pro-inflammatory mediators, such as prostaglandin E2, have been documented but especially the effects on synovial fluid anti-inflammatory mediators are less studied. In animal models hyaluronan has been demonstrated to reduce pain via protecting nociceptive nerve endings and by blocking pain receptor channels. However, the results obtained for pain-relief of human osteoarthritis are contradictory. The aim of the study was to measure the synovial fluid IL-1ra, PDGF-BB, TGF-β1 and TNF-α concentrations before and after surgically induced cartilage defect, and following intra-articular hyaluronan injection in horses. Eight Standardbred horses underwent bilateral arthroscopic surgeries of their intercarpal joints under general anaesthesia, and cartilage defect was created on the dorsal edge of the third carpal bone of one randomly selected intercarpal joint of each horse. Five days post-surgery, one randomly selected intercarpal joint was injected intra-articular with 3 mL HA (20 mg/mL).ResultsOperation type had no significant effect on the synovial fluid IL-1ra, PDGF-BB, TGF-β1 and TNF-α concentrations but compared with baseline, synovial fluid IL-1ra and TNF-α concentrations increased. Intra-articular hyaluronan had no significant effect on the biomarker concentrations but a trend of mild improvement in the clinical signs of intra-articular inflammation was seen.ConclusionsCreation of the cartilage defect and sham-operation lead to an increase of synovial fluid IL-1ra and TNF-α concentrations but changes in concentrations of anabolic growth factors TGF-β1 and PDGF-BB could not be documented 5 days after the arthroscopy. Intra-articular hyaluronan was well tolerated. Further research is needed to document possible treatment effects of intra-articular hyaluronan on the synovial fluid biomarkers of inflammation and cartilage metabolism.

Biochemical studies on proteoglycan content in affected cartilage, hyaluronic acid levels in serum and synovial fluid of perthes disease

Cartilage Proteoglycans and Hyaluronic Acid Levels in Serum and Synovial Fluid in Femoral Head Necrosis in Children

Biochemical studies on glucoaminoglycans content in affected cartilage hyaluronic acid levels in serum and synovial fluid of idiopathic femoral head necrosis

Changes in functional state of articular cartilage and its effects on the process in Legg-Perthes disease

Abnormal Proteoglycans Secreted by Chondrocytes in Actions of Fulvic-Acid and Reactive Oxygen Species

Changes in the metabolism of chondroitin sulfate glycosaminoglycans in articular cartilage from patients with Kashin-Beck disease.

Severe cartilage degeneration in patients with developmental dysplasia of the hip

Short-term clinical results of hip arthroscopy and ambulatory abduction brace for Perthes disease

Heparan sulfate functions are altered in the osteoarthritic cartilage

Comparison of the Curative Effect of Three Different Therapies in the Treatment of Perthes' Disease in Children

Evaluation of the effect of experimentally induced cartilage defect and intra-articular hyaluronan on synovial fluid biomarkers in intercarpal joints of horses

Increasing Expression of Substance P and Calcitonin Gene-Related Peptide in Synovial Tissue and Fluid Contribute to the Progress of Arthritis in Developmental Dysplasia of the Hip

Hyaluronan concentration and size distribution in human knee synovial fluid: variations with age and cartilage degeneration

Increasing substance P levels in serum and synovial tissues from patients with developmental dysplasia of the hip (DDH)

Diminished cartilage-lubricating ability of human osteoarthritic synovial fluid deficient in proteoglycan 4: Restoration through proteoglycan 4 supplementation

Expression of Platelet-Derived Growth Factor-a in the Hip Capsule of Children with Developmental Dysplasia of the Hip

Real-time Ultrasonic Assessment of Progressive Proteoglycan Depletion in Articular Cartilage.

Changes of Proteoglycan in Articular Cartilage Matrix of Osteoarthritis in Rabbits

Comprehensive analysis of pathological changes in hip joint capsule of patients with developmental dysplasia of the hip

A histological and ultrastructural study of femoral head cartilage in a new type II collagenopathy

Age At Onset-Dependent Presentations Of Premature Hip Osteoarthritis, Avascular Necrosis Of The Femoral Head, Or Legg-Calve-Perthes Disease In A Single Family, Consequent Upon A P.Gly1170ser Mutation Of Col2a1